Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Short-term survival and safety of apatinib combined with oxaliplatin and S-1 in the conversion therapy of unresectable gastric cancer

Fig. 3

Shor-term survival effect. a Overall survival curves of the non-surgical and surgical groups; b Overall survival curves of the non-peritoneal metastasis and peritoneal metastasis groups; c Overall survival curves of the R1/R2 resection group, R0 group and non-surgical group; d Overall survival curves of the different pathological responses

Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us